A new cancer Action Guide is equipping key stakeholders with targeted strategies to enhance efficiency and patient-centred care.

A topical treatment combining calcipotriol and 5-FU shows promise in reducing premalignant lesions and lowering skin cancer risk by activating Th2 immunity.

Published in Cell Reports Medicine, results of a VHIO-led study support the feasibility of using RAD51 testing to complement next-generation ...

Published in Cell Reports Medicine, results of a VHIO-led study support the feasibility of using RAD51 testing to complement ...

The Quezon City government in partnership with the Philippine Cancer Society (PCS) beefed up its cancer care programs and ...

While genetic testing rates for advanced ovarian cancer have increased, gaps in physician understanding and confidence in interpreting results may limit optimal biomarker-driven treatment and patient ...

Ms Christian revealed that Manx Care has consistently missed the 62-day referral-to-treatment standard, which requires 85 percent of patients to begin treatment within 62 days of a suspected cancer ...

Therapeutically targeting this pathway could potentially enhance the immune response to cancer. A research team at Memorial Sloan Kettering Cancer Center (MSK) has made new insights into how the body ...

Roche has secured a new FDA approval for its first companion diagnostic test aimed at identifying breast cancer patients with ...